D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Dick's Sporting Goods
DKS
$14.3B
| $81.8M | 0.04% |
360,838
+193,805
| +116% | +$42.8M |
2021 Q2
20 quarters
|
|
502
Travere Therapeutics
TVTX
$4.72B
| $81.8M | 0.04% |
1,440,469
+603,925
| +72% | +$26.8M |
2016 Q1
41 quarters
|
|
503
Victoria's Secret
VSXY
$7.24B
| $81.8M | 0.04% |
979,402
-438,435
| -31% | -$26.3M |
2021 Q3
19 quarters
|
|
504
Deckers Outdoor
DECK
$11B
| $81.5M | 0.04% |
820,888
-446,422
| -35% | -$47M |
2022 Q4
14 quarters
|
|
505
CALL
Zscaler
ZS
$41.6B
| $81.5M | 0.04% |
577,100
-52,000
| -8% | -$7.25M |
2018 Q4
30 quarters
|
|
506
CALL
AbbVie
ABBV
$505B
| $81.5M | 0.04% |
323,700
+26,800
| +9% | +$5.77M |
2013 Q2
52 quarters
|
|
507
Virtu Financial
VIRT
$4.94B
| $81.3M | 0.04% |
1,365,230
+202,297
| +17% | +$10.6M |
2020 Q4
22 quarters
|
|
508
Humana
HUM
$50.7B
| $81.2M | 0.04% |
204,543
-350,664
| -63% | -$100M |
2013 Q2
52 quarters
|
|
509
CALL
Rocket Lab Corp
RKLB
$33.6B
| $80.9M | 0.04% |
795,600
+62,500
| +9% | +$6.23M |
2024 Q4
6 quarters
|
|
510
Fidelity National Financial
FNF
$10.8B
| $80.6M | 0.04% |
1,709,587
+1,131,650
| +196% | +$54.8M |
2025 Q2
4 quarters
|
|
511
Corning
GLW
$107B
| $80.3M | 0.04% |
314,441
+178,392
| +131% | +$32.5M |
2024 Q2
8 quarters
|
|
512
Truist Financial
TFC
$59.2B
| $79.6M | 0.04% |
1,598,411
+1,483,852
| +1,295% | +$73M |
2020 Q4
22 quarters
|
|
513
Porch Group
PRCH
$2.01B
| $79.6M | 0.04% |
5,289,385
+927,585
| +21% | +$9.14M |
2021 Q4
18 quarters
|
|
514
CALL
Chevron
CVX
$457B
| $79.4M | 0.04% |
479,100
+12,200
| +3% | +$2.27M |
2013 Q2
52 quarters
|
|
515
Hilton Worldwide
HLT
$78.7B
| $79.4M | 0.04% |
240,298
+239,491
| +29,677% | +$78.7M |
2021 Q3
19 quarters
|
|
516
iShares US Real Estate ETF
IYR
$4.13B
| $79.2M | 0.04% |
+774,811
| New | +$78.6M |
2026 Q2
0 quarters
|
|
517
CALL
Astera Labs
ALAB
$44.6B
| $78.6M | 0.04% |
162,700
+81,200
| +100% | +$21.5M |
2024 Q4
6 quarters
|
|
518
Danaher
DHR
$162B
| $78.5M | 0.04% |
411,862
-1,016,386
| -71% | -$185M |
2016 Q2
40 quarters
|
|
519
CALL
MP Materials
MP
$6.82B
| $78.4M | 0.04% |
1,399,300
+304,300
| +28% | +$18.5M |
2024 Q1
9 quarters
|
|
520
Zillow
Z
$7.42B
| $78.1M | 0.04% |
2,478,834
+2,012,038
| +431% | +$77.3M |
2018 Q4
30 quarters
|
|
521
CALL
Applovin
APP
$87.1B
| $77.8M | 0.04% |
151,000
+40,400
| +37% | +$19.5M |
2023 Q4
10 quarters
|
|
522
PUT
CVS Health
CVS
$120B
| $77.8M | 0.04% |
751,900
-40,500
| -5% | -$3.62M |
2013 Q2
52 quarters
|
|
523
CALL
Enbridge
ENB
$107B
| $77.7M | 0.04% |
1,433,800
-34,900
| -2% | -$1.91M |
2019 Q4
26 quarters
|
|
524
Ford
F
$46.3B
| $77.3M | 0.04% |
5,561,886
-3,492,453
| -39% | -$47.1M |
2013 Q2
52 quarters
|
|
525
Cigna
CI
$81.1B
| $77.2M | 0.04% |
280,144
+255,574
| +1,040% | +$72.2M |
2014 Q4
46 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.